Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshihide Fujie is active.

Publication


Featured researches published by Toshihide Fujie.


Respiratory Physiology & Neurobiology | 2002

Effect of chest wall vibration on dyspnea during exercise in chronic obstructive pulmonary disease

Toshihide Fujie; Naoko Tojo; Naohiko Inase; Nobuo Nara; Ikuo Homma; Yasuyuki Yoshizawa

To elucidate the effect of in-phase chest wall vibration (IPV) during exercise, 17 COPD male patients performed two constant-load exercise tests on a cycle ergometer with and without IPV. The Borg dyspnea score significantly decreased from IPV (-) to IPV (+) (from 13.6+/-2.9 to 12.5+/-2.9, P<0.01). IPV elicited a significant increase in V(O(2)) (P<0.005) and significant decreases in both VE/V(O(2)) (P<0.05) and respiratory frequency (P<0.05), but it did not elicit any changes in VE. The change in Borg score between IPV (+) and IPV (-) showed a significant positive correlation with % predicted V(O(2),max) (r=0.71) and FEV(1)/FVC (r=0.69). Patients in the responsive group (n=11) showed significantly lower FEV(1) (P<0.05) and higher DeltaN(2)/L (P<0.01) than patients in the non-responsive group (n=6). We conclude that IPV reduces dyspnea and improves respiratory efficiency during aerobic exercise in severe COPD.


Antimicrobial Agents and Chemotherapy | 2014

First Report of KPC-2 Carbapenemase-Producing Klebsiella pneumoniae in Japan

Ryoichi Saito; Rieko Takahashi; Etsuko Sawabe; Saho Koyano; Yutaka Takahashi; Mari Shima; Hiroto Ushizawa; Toshihide Fujie; Naoki Tosaka; Yuko Kato; Kyoji Moriya; Shuji Tohda; Naoko Tojo; Ryuji Koike; Tetsuo Kubota

ABSTRACT We investigated a novel Japanese isolate of sequence type 11 (ST11), the Klebsiella pneumoniae carbapenemase-2 (KPC-2)-producing K. pneumoniae strain Kp3018, which was previously obtained from a patient treated at a Brazilian hospital. This strain was resistant to various antibiotic classes, including carbapenems, and harbored the gene blaKPC-2, which was present on the transferable plasmid of ca. 190 kb, in addition to the blaCTX-M-15 gene. Furthermore, the ca. 2.3-kb sequences (ISKpn8-blaKPC-2–ISKpn6-like), encompassing blaKPC-2, were found to be similar to those of K. pneumoniae strains from China.


Respiration | 2014

Serodiagnosis of Mycobacterium avium Complex Pulmonary Disease in Rheumatoid Arthritis

Yoshitoshi Komazaki; Yasunari Miyazaki; Toshihide Fujie; Hiroyuki Sakashita; Kimitake Tsuchiya; Meiyo Tamaoka; Yuki Sumi; Yuichiro Maruyama; Toshihiro Nanki; Naohiko Inase

Background:Mycobacterium avium complex (MAC) pulmonary disease (PD) is often difficult and complicated to diagnose or to discriminate from follicular bronchitis, bronchiectasis, or other conditions associated with rheumatoid arthritis (RA) lung in the clinical setting. Objective: We investigated whether a serologic test for anti-glycopeptidolipid (GPL) antibody was useful for distinguishing MAC-PD from RA lung in diagnosis. Methods: Serum IgA antibody to MAC-specific GPL core antigen was measured by an enzyme immunoassay. Antibody levels were measured in sera from 14 RA patients with MAC-PD (RA + MAC), 20 RA patients with bronchial or bronchiolar lesions without MAC-PD (RA w/o MAC), 20 RA patients without pulmonary lesions (RA only), and 25 healthy volunteers (HV). Results: The levels of serum anti-GPL antibodies were higher in the RA + MAC group than in the RA w/o MAC, RA-only, and HV groups (2.87 ± 2.83 vs. 0.50 ± 0.45, 0.31 ± 0.24, and 0.38 ± 0.10 U/ml, respectively; p < 0.001). With the cutoff point in receiver-operating characteristic analysis set at 0.7 U/ml, the serologic test differentiated RA + MAC from RA w/o MAC with a sensitivity of 100% and specificity of 90%. Conclusions: This serologic test for anti-GPL antibody is useful for diagnosing MAC-PD in RA.


Case Reports | 2012

Bronchiolitis obliterans organising pneumonia syndrome presenting with neutrophilia in bronchoalveolar lavage fluid after breast-conserving therapy.

Sahoko Chiba; Torahiko Jinta; Naohiko Chohnabayashi; Toshihide Fujie; Yuki Sumi; Naohiko Inase

A 61-year-old female presented with a dry cough and fever 4 months after tangential radiation therapy (RT) following conserving surgery for breast cancer. Chest radiography and CT demonstrated consolidation with air bronchogram outside the irradiated area. Neutrophil granulocytes were abundant in bronchoalveolar lavage fluid (BALF) (39.6% of total cells), and transbronchial lung biopsy revealed organising pneumonia (OP) histologically. Antibiotic therapy had no effect, but corticosteroid therapy brought about clinical improvement. Her condition was diagnosed as bronchiolitis obliterans OP (BOOP) syndrome. Lymphocytic BALF has been identified as a characteristic of BOOP syndrome induced after RT for breast cancer. The BALF in this case, however, was neutrophilic. In our analysis of differential cell counts in the BALF of 24 patients with BOOP syndrome, the BALF was neutrophilic (>5%) in 16 (76%) cases, and the neutrophilia was severe in some of those patients.


Respiratory investigation | 2015

Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitis

Toshiharu Tsutsui; Yasunari Miyazaki; Tsukasa Okamoto; Tomoya Tateishi; Haruhiko Furusawa; Kimitake Tsuchiya; Toshihide Fujie; Meiyo Tamaoka; Hiroyuki Sakashita; Yuki Sumi; Naohiko Inase

BACKGROUND Chronic hypersensitivity pneumonitis (HP) is induced by the inhalation of specific antigens. Patients with chronic HP may be able to improve their prognosis by avoiding these antigens. Chronic HP is often difficult to distinguish from idiopathic interstitial pneumonias (IIPs). OBJECTIVE This study was performed to find out how antigen avoidance tests contribute to the diagnosis of chronic HP. METHODS A retrospective analysis was conducted on 265 patients who underwent 2-week antigen avoidance tests between April 2002 and March 2012. The patients were classified into the following categories: acute HP, chronic HP, collagen vascular disease-associated interstitial pneumonia (CVD-IP), lung dominant connective tissue disease (LD-CTD), and IIPs. The following seven clinical parameters were evaluated: vital capacity, alveolar-arterial oxygen pressure difference, Krebs von den Lungen-6, surfactant protein-D, white blood cell count, C-reactive protein, and body temperature. These parameters were compared between the chronic HP group and a control group consisting of CVD-IP, LD-CTD, and IIPs. RESULTS One-hundred and ninety-six patients with chronic HP and 43 control subjects were evaluated. All clinical parameters improved significantly in the chronic HP group but showed no significant changes in the control group. Four of the parameters changed significantly compared with the control group. Diagnostic criteria established using these data had a sensitivity of 51.0% and a specificity of 80.7%. CONCLUSIONS It was difficult to diagnose chronic HP based solely on 2-week antigen avoidance tests; however, improved clinical parameters among patients supported the diagnosis of HP.


Respiratory investigation | 2016

Factors associated with positive inhalation provocation test results in subjects suspected of having chronic bird-related hypersensitivity pneumonitis

Masahiro Masuo; Yasunari Miyazaki; Kozo Suhara; Masahiro Ishizuka; Toshihide Fujie; Naohiko Inase

BACKGROUND Chronic bird-related hypersensitivity pneumonitis (BRHP) is often misdiagnosed as other interstitial lung diseases. While the utility of the inhalation provocation test (IPT) has been reported, the test is not commonly performed. In this study, we aimed to identify significant clinical variables associated with positive inhalation provocation test results in subjects suspected of having chronic BRHP. This would help clinicians decide whether to perform IPT in patients suspected of having chronic BRHP in real-life practice. METHODS We retrospectively evaluated 107 patients who underwent the IPT for suspected chronic BRHP. We used the IPT as the gold standard diagnostic tool for chronic BRHP. RESULTS Specific antibodies against pigeon dropping extract were documented in 52% of the IPT-positive patients but also in 38% of the IPT-negative patients (p=0.172). By using the logistic regression model, three significant predictors of IPT results were identified as follows: (1) a history of raising birds (odds ratio [OR] 3.112), (2) exposure to birds from the surrounding environment (OR 7.321), (3) white blood cell count (×102/μl; OR 0.959). CONCLUSIONS This study demonstrates that current or past exposure to avian antigens is a positive predictor of positive IPT results in patients suspected of having chronic BRHP.


Chemotherapy | 2013

Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.

Yoshitoshi Komazaki; Hiroyuki Sakashita; Masashi Furuiye; Toshihide Fujie; Meiyo Tamaoka; Yuki Sumi; Yasunari Miyazaki; Katsuo Kojima; Yasuto Jin; Naohiko Inase

Background: The purpose of this study was to evaluate the feasibility and compliance of adjuvant chemotherapy of S-1 plus carboplatin for patients with completely resected non-small cell lung cancer (NSCLC) of pathological stage IB-IIIB. Methods: S-1 was given orally at a dose of 80 mg/m2/day for 2 weeks, followed by a 2-week period of no treatment. Carboplatin was given intravenously on day 8 at an area under the curve of 6. This regimen was repeated for four to six 28-day courses. Results: Seventeen patients were enrolled in this study. Fourteen of them completed at least 4 cycles of chemotherapy. Nine patients had grade 2 and three patients had grade 3 thrombocytopenia, respectively. Severe nonhematologic toxicities were uncommon. Treatment was delayed in a few patients because of prolonged thrombocytopenia. Conclusion: We concluded that the regimen was feasible and tolerable for patients with completely resected NSCLC as adjuvant chemotherapy.


Respiration | 2017

Radiopathological Features and Identification of Mycobacterial Infections in Granulomatous Nodules Resected from the Lung

Yumi Sakakibara; Yoshimi Suzuki; Toshihide Fujie; Takumi Akashi; Tadatsune Iida; Yasunari Miyazaki; Yoshinobu Eishi; Naohiko Inase

Background: Pulmonary granulomas are sometimes resected because they resemble lung cancer and false-positive findings come through from positron emission tomography (PET) using 18fluorine-fluorodeoxyglucose (18F-FDG). Mycobacterial infection is a common cause of granulomas. Objective: The purpose of this study was to evaluate the radiopathological features and the methods for identifying mycobacterial infections in granulomatous nodules resected from the lung. Methods: Thirty-five solitary lesions resected because of suspected lung cancer were enrolled, including 22 nonfungal granulomatous lesions and 13 benign lesions as controls. The radiological, microbiological, and histological findings were reviewed. To identify mycobacterial infection, immunohistochemical (IHC) staining, IS6110 polymerase chain reaction (PCR), and real-time PCR for the detection of Mycobacterium tuberculosis (TB) were performed using formalin-fixed and paraffin-embedded tissue specimens. The correlations between the radiopathological features and the median maximum standardized uptake value (SUVmax) of 18F-FDG PET were also evaluated. Results: Mycobacteria were isolated from the cultures of 10 of the granulomatous lesions, including TB from 2 and Mycobacterium avium complex from 8. The mean size of the nodules in the culture-positive group was significantly larger than that of those in the culture-negative group (30.5 ± 13.1 vs. 15.1 ± 6.3 mm, p = 0.003). IHC stainings were positive in 15 granulomas. Eight granulomas were positive in IS6110 PCR, and 7 of them were also positive in real-time PCR. SUVmax was ≥2.5 in all of the PCR-positive granulomas. Conclusion: The most frequent cause of granulomatous lesions was mycobacterial infection. It seemed that the culture result was associated with nodule size and that the results of IS6110 were associated with 18F-FDG-uptake.


International Scholarly Research Notices | 2013

Lung Cancer Diagnosed More Than Five Years after the Development of Polymyositis/Dermatomyositis

Ken Uchibori; Tomoyuki Ogata; Tuyoshi Shirai; Shuta Yamauchi; Masahiro Masuo; Sahoko Chiba; Haruhiko Furusawa; Kimitake Tsuchiya; Toshihide Fujie; Meiyo Tamaoka; Hiroyuki Sakashita; Yuki Sumi; Yasunari Miyazaki; Naohiko Inase

Background. The patients with polymyositis (PM) and dermatomyositis (DM) often develop the malignancies in their clinical course. The incidence of cancer is estimated at about 15%. The risk of cancer is the highest within the first year of myositis diagnosis and drops substantially thereafter. The patients with lung cancer diagnosed more than 5 years after the onset of PM or DM are the minority. Methods and Patients. We surveyed the medical records of patients with lung cancer over the period from 1995 to 2011. Results. We found five patients who developed lung cancer more than 5 years after the diagnosis of PM/DM. Three patients were male, and two were female. The median age was 61.2 (±11.7). Histological types were diverse. The clinical stages ranged from IA to IV. Three patients had smoking histories. Four patients suffered from DM, and one suffered from PM. All patients received oral corticosteroid therapy. Two patients also received ciclosporin, and another two received azathioprine. Anti-Jo-1 antibody was positive in one patient. Four patients were complicated with interstitial pneumonia (IP). Conclusion. These lung cancers diagnosed more than 5 years after the onset of PM/DM were probably related to IP or smoking but might not be comorbid with PM/DM.


European Journal of Clinical Microbiology & Infectious Diseases | 2015

Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan

Y. Kuwata; S. Tanimoto; Etsuko Sawabe; Mari Shima; Yutaka Takahashi; Hiroto Ushizawa; Toshihide Fujie; Ryuji Koike; Naoko Tojo; Tetsuo Kubota; Ryoichi Saito

Collaboration


Dive into the Toshihide Fujie's collaboration.

Top Co-Authors

Avatar

Naohiko Inase

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Yasunari Miyazaki

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Yuki Sumi

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Meiyo Tamaoka

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Hiroyuki Sakashita

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Haruhiko Furusawa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Sahoko Chiba

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Tomoya Tateishi

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tsukasa Okamoto

Tokyo Medical and Dental University

View shared research outputs
Researchain Logo
Decentralizing Knowledge